FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anne-Marie Cleton-Jansen

Research Profile

Disorders

Anatomy

Genes & Molecular Sequences

Genes, Tumor Suppressor

Procedures

Physiology

Chemicals & Drugs

Concepts & Ideas

Molecular Sequence Data

Devices

Oligonucleotide Array Sequence Analysis

Co-author Network

Publications

TOP 3
Maurits de Vries; Inge Briaire-de Bruijn; Anne-Marie Cleton-Jansen; Martijn J A Malessy; Andel G L van der Mey; Pancras C W Hogendoorn
Mutations affecting BRAF, EGFR, PIK3CA, and KRAS are not associated with sporadic vestibular schwannomas.
Aaron L Sarver; Milcah C Scott; Anne-Marie Cleton-Jansen; Pancras Cw Hogendoorn; Jaime F Modiano; Venugopal Thayanithy; Subbaya Subramanian
MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.
Alexander B Mohseny; Peter ten Dijke; Brendy van den Akker; Wei Xiao; Carlos E de Andrea; Pancras C W Hogendoorn; Rutger Jacobs; Marieke Kuijjer; Yongping Cai; Anne-Marie Cleton-Jansen
The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anne-Marie Cleton-Jansen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Maurits de Vries; Inge Briaire-de Bruijn; Anne-Marie Cleton-Jansen; Martijn J A Malessy; Andel G L van der Mey; Pancras C W Hogendoorn
Mutations affecting BRAF, EGFR, PIK3CA, and KRAS are not associated with sporadic vestibular schwannomas.
Virchows Archiv : an international journal of pathology 2013;462(2):211-7.
2013: Aaron L Sarver; Milcah C Scott; Anne-Marie Cleton-Jansen; Pancras Cw Hogendoorn; Jaime F Modiano; Venugopal Thayanithy; Subbaya Subramanian
MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.
Orphanet journal of rare diseases 2013;8():7.
2012: Alexander B Mohseny; Peter ten Dijke; Brendy van den Akker; Wei Xiao; Carlos E de Andrea; Pancras C W Hogendoorn; Rutger Jacobs; Marieke Kuijjer; Yongping Cai; Anne-Marie Cleton-Jansen
The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma.
European journal of cancer (Oxford, England : 1990) 2012;48(18):3429-38.
2012: Jantine Posthumadeboer; Pim W van Egmond; Barend J van Royen; Hendrik Verheul; Jeroen A M Beliën; Anne-Marie Cleton-Jansen; Renée X de Menezes; Marco N Helder; Gert-Jan J L Kaspers; Victor W van Beusechem
Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin.
Oncotarget 2012;3(10):1169-81.
2012: Kristiaan Lenos; Kirsten Lodder; Emmanouela Repapi; Helge Taubert; Amina Teunisse; Peter Wuerl; Frank Bartel; Gareth Bond; Anne-Marie Cleton-Jansen; Anna M Grawenda; Lukasz F Grochola; Pancras C W Hogendoorn; Marieke L Kuijjer; Aart G Jochemsen
Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer.
Cancer research 2012;72(16):4074-84.
2012: Marieke L Kuijjer; Ana B Lid; Leonardo A. Meza-Zepeda; Ola Myklebost; Helene Roelofs; Halfdan Rydbeck; Emilie P Buddingh; Horst Bürger; Pancras C W Hogendoorn; Stine H Kresse; Anne-Marie Cleton-Jansen
Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data.
Genes, chromosomes & cancer 2012;51(7):696-706.
2012: Alexander B Mohseny; Herman P Spaink; Wei Xiao; Ralph Carvalho; Pancras C W Hogendoorn; Anne-Marie Cleton-Jansen
An osteosarcoma zebrafish model implicates Mmp-19 and Ets-1 as well as reduced host immune response in angiogenesis and migration.
The Journal of pathology 2012;227(2):245-53.
2012: J G van Oosterwijk; Inge H Briaire-de Bruijn; Anne-Marie Cleton-Jansen; Hans Gelderblom; B Herpers; D Meijer; Bob van de Water; Judith Bovee
Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(6):1617-26.
2012: Karoly Szuhai; Anne-Marie Cleton-Jansen; Pancras C W Hogendoorn; Judith Bovee
Molecular pathology and its diagnostic use in bone tumors.
Cancer genetics 2012;205(5):193-204.
2012: Stine H Kresse; Knut Liestøl; Ana H Barragan-Polania; Anne-Marie Cleton-Jansen; Pancras C W Hogendoorn; Eivind Hovig; Ola Myklebost; Heidi Maria Namløs; Halfdan Rydbeck; Massimo Serra; Magne Skårn; Leonardo A. Meza-Zepeda
Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma.
PloS one 2012;7(11):e48262.
2012: Heidi Maria Namløs; Massimo Serra; Ingrid H G Østensen; Tale Barøy; Horst Bürger; Anne-Marie Cleton-Jansen; Stine H Kresse; Marieke L Kuijjer; Leonardo A. Meza-Zepeda; Ola Myklebost
Modulation of the osteosarcoma expression phenotype by microRNAs.
PloS one 2012;7(10):e48086.
2012: Stephane Boeuf; Judith Bovee; Anne-Marie Cleton-Jansen; Burkhard Lehner; Brendy van den Akker; Maayke van Ruler; Wiltrud Richter
BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors.
BMC cancer 2012;12():488.
2012: Alexander B Mohseny; Pancras C W Hogendoorn; Anne-Marie Cleton-Jansen
Osteosarcoma models: from cell lines to zebrafish.
Sarcoma 2012;2012():417271.
2011: Twinkal C Pansuriya; Luca Sangiorgi; Mikel San-Julian; Raf Sciot; Karoly Szuhai; Berkin Toker; Ronald van Eijk; Jolieke G van Oosterwijk; Maayke A J H van Ruler; Tom van Wezel; Sofie L J Verbeke; Miikka Vikkula; Anne-Marie Cleton-Jansen; Pio d'Adamo; Soeren Daugaard; Pim J French; Catherine Godfraind; Lars-Gunnar Kindblom; Marieke L Kuijjer; Kyle C Kurek; Bernadette Liegl-Atzwanger; Nisha Limaye; Daniëlle Meijer; Karolin H Nord; Jan Oosting; Laurence M Boon; Judith Bovee
Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome.
Nature genetics 2011;43(12):1256-61.
2011: Alexander B Mohseny; Karl-Ludwig Schaefer; Massimo Serra; Yongping Cai; Pancras C W Hogendoorn; Antonio Llombart Bosch; Isidro Machado; Anne-Marie Cleton-Jansen
Functional characterization of osteosarcoma cell lines provides representative models to study the human disease.
Laboratory investigation; a journal of technical methods and pathology 2011;91(8):1195-205.
2011: Danielle Meijer; Anne-Marie Cleton-Jansen; Hans Gelderblom; Pancras C W Hogendoorn; Marcel Karperien; Judith V M G Bovee
Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo.
Clinical sarcoma research 2011;1(1):5.
2011: Emilie P Buddingh; Marieke L Kuijjer; Ronald A J Duim; Horst Bürger; Konstantin Agelopoulos; Ola Myklebost; Massimo Serra; Fredrik Mertens; Pancras C W Hogendoorn; Arjan C Lankester; Anne-Marie Cleton-Jansen
Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(8):2110-9.
2011: Marieke L Kuijjer; Antonio Llombart Bosch; Isidro Machado; Leonardo A. Meza-Zepeda; Ola Myklebost; Heidi M Namløs; Massimo Serra; Esther I Hauben; Pancras C W Hogendoorn; Stine H Kresse; Anne-Marie Cleton-Jansen
mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts.
BMC medical genomics 2011;4():66.
2010: Alexander B Mohseny; Chris Tieken; Pieter A van der Velden; Karoly Szuhai; Carlos de Andrea; Pancras C W Hogendoorn; Anne-Marie Cleton-Jansen
Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcoma.
Genes, chromosomes & cancer 2010;49(12):1095-103.
2010: Helen J Knowles; Anne-Marie Cleton-Jansen; Eberhard Korsching; Nicholas A Athanasou
Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010;24(12):4648-59.
2010: Marjo de Graauw; Martine H van Miltenburg; Marjanka K Schmidt; Chantal Pont; Reshma Lalai; Joelle Kartopawiro; Evangelia Pardali; Sylvia E Le Dévédec; Vincent T Smit; Annemieke van der Wal; Laura J van't Veer; Anne-Marie Cleton-Jansen; Peter ten Dijke; Bob van de Water
Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(14):6340-5.
2010: Stine H Kresse; Karoly Szuhai; Ana H Barragan-Polania; Halfdan Rydbeck; Anne-Marie Cleton-Jansen; Ola Myklebost; Leonardo A. Meza-Zepeda
Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours.
BMC research notes 2010;3():223.
2010: Ronald van Eijk; Paul H C Eilers; Remco Natté; Anne-Marie Cleton-Jansen; Hans Morreau; Tom van Wezel; Jan Oosting
MLPAinter for MLPA interpretation: an integrated approach for the analysis, visualisation and data management of Multiplex Ligation-dependent Probe Amplification.
BMC bioinformatics 2010;11():67.
2010: Ronald van Eijk; Marjo Van Puijenbroek; Amiet R Chhatta; Nisha Gupta; Rolf H A M Vossen; Esther H Lips; Anne-Marie Cleton-Jansen; Hans Morreau; Tom van Wezel
Sensitive and specific KRAS somatic mutation analysis on whole-genome amplified DNA from archival tissues.
The Journal of molecular diagnostics : JMD 2010;12(1):27-34.
2010: Yongping Cai; Alexander B Mohseny; Marcel Karperien; Pancras C W Hogendoorn; Gengyin Zhou; Anne-Marie Cleton-Jansen
Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.
The Journal of pathology 2010;220(1):24-33.
2010: Laura Ottaviano; Karl-Ludwig Schaefer; Melanie Gajewski; Wolfgang Huckenbeck; Stefan Baldus; Uwe Rogel; Carlos Mackintosh; Enrique de Alava; Ola Myklebost; Stine H Kresse; Leonardo A. Meza-Zepeda; Massimo Serra; Anne-Marie Cleton-Jansen; Pancras C W Hogendoorn; Horst Buerger; Thomas Aigner; Helmut E Gabbert; Christopher Poremba
Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort.
Genes, chromosomes & cancer 2010;49(1):40-51.
2009: Anne-Marie Cleton-Jansen; J K Anninga; Inge H Briaire-de Bruijn; Salvatore Romeo; Jan Oosting; R Maarten Egeler; Hans Gelderblom; Antonie H M Taminiau; P C W Hogendoorn
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways.
British journal of cancer 2009;101(11):1909-18.
2009: Alexander B Mohseny; Karoly Szuhai; Salvatore Romeo; Emilie P Buddingh; Inge Briaire-de Bruijn; Daniëlle de Jong; Melissa van Pel; Anne-Marie Cleton-Jansen; Pancras C W Hogendoorn
Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.
The Journal of pathology 2009;219(3):294-305.
2009: Yvonne M Schrage; Suzanne Lam; Aart G Jochemsen; Anne-Marie Cleton-Jansen; Antonie H M Taminiau; Pancras C W Hogendoorn; Judith Bovee
Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro.
Journal of cellular and molecular medicine 2009;13(9A):2843-52.
2009: Stefan Willems; Alex B Mohseny; Crina Balog; Raj Sewrajsing; Inge H Briaire-de Bruijn; Jeroen Knijnenburg; Anne-Marie Cleton-Jansen; Raf Sciot; Christopher D M Fletcher; André M Deelder; Karoly Szuhai; Paul J Hensbergen; Pancras C W Hogendoorn
Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix.
Journal of cellular and molecular medicine 2009;13(7):1291-301.
2009: Karolin H Hallor; Johan Staaf; Judith Bovee; Pancras Hogendoorn; Anne-Marie Cleton-Jansen; Sakari Knuutila; Suvi Savola; Tarja Niini; Otte Brosjö; Henrik C F Bauer; Fredrik Vult von Steyern; Kjell Jonsson; Mikael Skorpil; Nils Mandahl; Fredrik Mertens
Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(8):2685-94.
2009: Yvonne M Schrage; Liesbeth Hameetman; Karoly Szuhai; Anne-Marie Cleton-Jansen; Antonie H M Taminiau; Pancras Hogendoorn; Judith Bovee
Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma.
The American journal of pathology 2009;174(3):979-88.
2008: Anne-Marie Cleton-Jansen; Ronald van Eijk; Marcel Lombaerts; Marjanka K Schmidt; Laura J van't Veer; Katja Philippo; Rhyenne M E Zimmerman; Johannes L Peterse; Vincent T B H M Smit; Tom van Wezel; Cees J Cornelisse
ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.
BMC cancer 2008;8():105.
2007: Célia M F Gomes; Mick Welling; Ivo Que; Nico Henriquez; Gabri van der Pluijm; Salvatore Romeo; Antero J Abrunhosa; M Filomena Botelho; Pancras Hogendoorn; Ernest K J Pauwels; Anne-Marie Cleton-Jansen
Functional imaging of multidrug resistance in an orthotopic model of osteosarcoma using 99mTc-sestamibi.
European journal of nuclear medicine and molecular imaging 2007;34(11):1793-803.
2007: Jeroen T Buijs; Nico Henriquez; Petra G M van Overveld; Gijsbertus T J van der Horst; Ivo Que; Ruth Schwaninger; Cyrill Rentsch; Peter ten Dijke; Anne-Marie Cleton-Jansen; Keltouma Driouch; Rosette Lidereau; Richard Bachelier; Slobodan Vukicevic; Philippe Clézardin; Socrates E Papapoulos; Marco G Cecchini; Clemens W G M Löwik; Gabri van der Pluijm
Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Cancer research 2007;67(18):8742-51.
2007: Salvatore Romeo; Jan Oosting; Leida B Rozeman; Liesbeth Hameetman; Antonie H M Taminiau; Anne-Marie Cleton-Jansen; Judith Bovee; Pancras Hogendoorn
The role of noncartilage-specific molecules in differentiation of cartilaginous tumors: lessons from chondroblastoma and chondromyxoid fibroma.
Cancer 2007;110(2):385-94.
2007: Liesbeth Hameetman; Karoly Szuhai; Ayse Yavas; Jeroen Knijnenburg; Mark van Duin; Herman van Dekken; Antonie H M Taminiau; Anne-Marie Cleton-Jansen; Judith Bovee; Pancras Hogendoorn
The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions.
Journal of the National Cancer Institute 2007;99(5):396-406.
2007: Liesbeth Hameetman; G David; Ayse Yavas; Stefan J White; Antonie H M Taminiau; Anne-Marie Cleton-Jansen; Pancras Hogendoorn; Judith Bovee
Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.
The Journal of pathology 2007;211(4):399-409.
2007: Shawn Patrick Grogan; Andrea Barbero; Jose Diaz-Romero; Anne-Marie Cleton-Jansen; Stephan Soeder; Robert Whiteside; Pancras Hogendoorn; jian farhadi; Thomas Aigner; Ivan Martin; PIerre Mainil-Varlet
Identification of markers to characterize and sort human articular chondrocytes with enhanced in vitro chondrogenic capacity.
Arthritis and rheumatism 2007;56(2):586-95.
2006: Leida B Rozeman; Anne-Marie Cleton-Jansen; Pancras Hogendoorn
Pathology of primary malignant bone and cartilage tumours.
International orthopaedics 2006;30(6):437-44.
2006: Célia M F Gomes; Heidi van Paassen; Salvatore Romeo; Mick Welling; R I J Feitsma; Antero J Abrunhosa; M Filomena Botelho; Pancras Hogendoorn; Ernest K J Pauwels; Anne-Marie Cleton-Jansen
Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies.
Nuclear medicine and biology 2006;33(7):831-40.
2006: Liesbeth Hameetman; Leida B Rozeman; Marcel Lombaerts; Jan Oosting; Antonie H M Taminiau; Anne-Marie Cleton-Jansen; Judith Bovee; Pancras Hogendoorn
Peripheral chondrosarcoma progression is accompanied by decreased Indian Hedgehog signalling.
The Journal of pathology 2006;209(4):501-11.
2006: Leida B Rozeman; Karoly Szuhai; Yvonne M Schrage; Carla Rosenberg; Hans J Tanke; Antonie H M Taminiau; Anne-Marie Cleton-Jansen; Judith Bovee; Pancras Hogendoorn
Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations.
Cancer 2006;107(2):380-8.
2006: Rogier A Oldenburg; Karin Kroeze-Jansema; Hanne Meijers-Heijboer; Christi J van Asperen; Nicoline Hoogerbrugge; Inge van Leeuwen; H F A Vasen; Anne-Marie Cleton-Jansen; Jaennelle Kraan; Jeanine J Houwing-Duistermaat; Hans Morreau; Cees J Cornelisse; Peter Devilee
Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1693-700.
2006: Marcel Lombaerts; Tom van Wezel; Katja Philippo; Jan Willem F Dierssen; R M E Zimmerman; Jan Oosting; Ronald van Eijk; Paul H C Eilers; Bob van de Water; Cees J Cornelisse; Anne-Marie Cleton-Jansen
E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines.
British journal of cancer 2006;94(5):661-71.
2005: Raman Kumar; Paul M Neilsen; Joanna Crawford; Ross McKirdy; Jaclyn Lee; Jason A Powell; Zarqa Saif; Julie M Martin; Marcel Lombaerts; Cees J Cornelisse; Anne-Marie Cleton-Jansen; David F Callen
FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex.
Cancer research 2005;65(24):11304-13.
2005: Anne-Marie Cleton-Jansen; Hetty M van Beerendonk; Hans J Baelde; Judith Bovee; Marcel Karperien; Pancras Hogendoorn
Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(22):8028-35.
2005: Marjo Van Puijenbroek; Jan Willem F Dierssen; Patrick Stanssens; Ronald van Eijk; Anne-Marie Cleton-Jansen; Tom van Wezel; Hans Morreau
Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer.
The Journal of molecular diagnostics : JMD 2005;7(5):623-30.
2005: Esther Hauben; Gernot Jundt; Anne-Marie Cleton-Jansen; Ayse Yavas; Herman M Kroon; Eric Van Marck; Pancras Hogendoorn
Desmoplastic fibroma of bone: an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin.
Human pathology 2005;36(9):1025-30.
2005: Leida B Rozeman; Liesbeth Hameetman; Tom van Wezel; Antonie H M Taminiau; Anne-Marie Cleton-Jansen; Pancras Hogendoorn; Judith Bovee
cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade.
The Journal of pathology 2005;207(1):61-71.
2005: Judith Bovee; Anne-Marie Cleton-Jansen; Antonie H M Taminiau; Pancras Hogendoorn
Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment.
The lancet oncology 2005;6(8):599-607.
2005: Remco Natté; Ronald van Eijk; Paul H C Eilers; Anne-Marie Cleton-Jansen; Jan Oosting; Mathilde Kouwenhove; Johan M Kros; Sjoerd G van Duinen
Multiplex ligation-dependent probe amplification for the detection of 1p and 19q chromosomal loss in oligodendroglial tumors.
Brain pathology (Zurich, Switzerland) 2005;15(3):192-7.
2005: Salvatore Romeo; Judith Bovee; Shawn Patrick Grogan; Antonie H M Taminiau; Paul H C Eilers; Anne-Marie Cleton-Jansen; PIerre Mainil-Varlet; Pancras Hogendoorn
Chondromyxoid fibroma resembles in vitro chondrogenesis, but differs in expression of signalling molecules.
The Journal of pathology 2005;206(2):135-42.
2005: Jelle J Goeman; Jan Oosting; Anne-Marie Cleton-Jansen; Jakob K Anninga; Hans C van Houwelingen
Testing association of a pathway with survival using gene expression data.
Bioinformatics (Oxford, England) 2005;21(9):1950-7.
2005: Liesbeth Hameetman; Petra Kok; Paul H C Eilers; Anne-Marie Cleton-Jansen; Pancras Hogendoorn; Judith Bovee
The use of Bcl-2 and PTHLH immunohistochemistry in the diagnosis of peripheral chondrosarcoma in a clinicopathological setting.
Virchows Archiv : an international journal of pathology 2005;446(4):430-7.
2005: Leida B Rozeman; Liesbeth Hameetman; Anne-Marie Cleton-Jansen; Antonie H M Taminiau; Pancras Hogendoorn; Judith Bovee
Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas.
The Journal of pathology 2005;205(4):476-82.
2005: Tom van Wezel; Marcel Lombaerts; Eddy H van Roon; Katja Philippo; Hans J Baelde; Karoly Szuhai; Cees J Cornelisse; Anne-Marie Cleton-Jansen
Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.
Breast cancer research : BCR 2005;7(6):R998-1004.
2004: Leida B Rozeman; Luca Sangiorgi; Inge H Briaire-de Bruijn; PIerre Mainil-Varlet; F Bertoni; Anne-Marie Cleton-Jansen; Pancras Hogendoorn; Judith Bovee
Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C.
Human mutation 2004;24(6):466-73.
2004: Anne-Marie Cleton-Jansen; Horst Buerger; Natalja ter Haar; Katja Philippo; Marc J van de Vijver; Werner Boecker; Vincent T H B M Smit; Cees J Cornelisse
Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer.
Genes, chromosomes & cancer 2004;41(2):109-16.
2004: Marcel Lombaerts; Janneke W Middeldorp; Esther van der Weide; Katja Philippo; Tom van Wezel; Vincent T H B M Smit; Cees J Cornelisse; Anne-Marie Cleton-Jansen
Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors.
Biochemical and biophysical research communications 2004;319(2):697-704.
2004: J K Anninga; Marc J van de Vijver; Anne-Marie Cleton-Jansen; P M P Kristel; Antonie H M Taminiau; Marianne A Nooij; R Maarten Egeler; Pancras Hogendoorn
Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas.
European journal of cancer (Oxford, England : 1990) 2004;40(7):963-70.
2004: Ronald van Eijk; Jan Oosting; Nathalie L G Sieben; Tom van Wezel; Anne-Marie Cleton-Jansen
Visualization of regional gene expression biases by microarray data sorting.
BioTechniques 2004;36(4):592-4, 596.
2004: Hetty M van Beerendonk; Leida B Rozeman; Antonie H M Taminiau; Raf Sciot; Judith Bovee; Anne-Marie Cleton-Jansen; Pancras Hogendoorn
Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
The Journal of pathology 2004;202(3):359-66.
2004: Anne-Marie Cleton-Jansen; Michel C Timmerman; Marc J van de Vijver; Christi J van Asperen; Herman M Kroon; Paul H C Eilers; Pancras Hogendoorn
A distinct phenotype characterizes tumors from a putative genetic trait involving chondrosarcoma and breast cancer occurring in the same patient.
Laboratory investigation; a journal of technical methods and pathology 2004;84(2):191-202.
2003: Nathalie L G Sieben; Sandra M Kolkman-Uljee; Adrienne M Flanagan; Saskia Le Cessie; Anne-Marie Cleton-Jansen; Cees J Cornelisse; Gert Jan Fleuren
Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors.
The American journal of pathology 2003;162(4):1095-101.
2002: Marina Kochetkova; Olivia L D McKenzie; Anthony J Bais; Julie M Martin; Genevieve A Secker; Ram Seshadri; Jason A Powell; Susan J Hinze; Alison E Gardner; Hayley E Spendlove; Nathan O'Callaghan; Anne-Marie Cleton-Jansen; Cees J Cornelisse; Scott A Whitmore; Joanna Crawford; Gabriel Kremmidiotis; Grant R Sutherland; David F Callen
CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
Cancer research 2002;62(16):4599-604.
2002: Karl-Friedrich Becker; Elisabeth Kremmer; Manfred Eulitz; Stephan Schulz; Jörg Mages; Gabriele Handschuh; Margaret J Wheelock; Anne-Marie Cleton-Jansen; Heinz Höfler; Ingrid Becker
Functional allelic loss detected at the protein level in archival human tumours using allele-specific E-cadherin monoclonal antibodies.
The Journal of pathology 2002;197(5):567-74.
2002: David F Callen; Joanna Crawford; Cathy Derwas; Anne-Marie Cleton-Jansen; Cees J Cornelisse; Elizabeth Baker
Defining regions of loss of heterozygosity of 16q in breast cancer cell lines.
Cancer genetics and cytogenetics 2002;133(1):76-82.
2002: Anne-Marie Cleton-Jansen
E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?
Breast cancer research : BCR 2002;4(1):5-8.
2002: Galina N Filippova; Chen-Feng Qi; Jonathan E Ulmer; James M Moore; Michael D Ward; Ying J Hu; Dmitri Loukinov; Elena Pugacheva; Elena Klenova; Paul E Grundy; Andrew P Feinberg; Anne-Marie Cleton-Jansen; Elna W Moerland; Cees J Cornelisse; Hiroyoshi Suzuki; Akira Komiya; Annika Lindblom; Françoise Dorion-Bonnet; Paul E Neiman; Herbert C Morse; Steven J Collins; Victor Lobanenkov
Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificity.
Cancer research 2002;62(1):48-52.
2001: Hans J Baelde; Anne-Marie Cleton-Jansen; Hetty M van Beerendonk; M Namba; Judith Bovee; Pancras Hogendoorn
High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma.
Journal of clinical pathology 2001;54(10):778-82.
2001: Judith Bovee; L J C M van den Broek; Anne-Marie Cleton-Jansen; Pancras Hogendoorn
Chondrosarcoma is not characterized by detectable telomerase activity.
The Journal of pathology 2001;193(3):354-60.
2001: Anne-Marie Cleton-Jansen; David F Callen; Ram Seshadri; S Goldup; B Mccallum; Joanna Crawford; Jason A Powell; C Settasatian; Hetty M van Beerendonk; Elna W Moerland; Vincent T H B M Smit; W H Harris; R Millis; Neil V Morgan; D Barnes; Christopher G Mathew; Cees J Cornelisse
Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
Cancer research 2001;61(3):1171-7.
2001: S M Langezaal; J Frans Graadt van Roggen; Anne-Marie Cleton-Jansen; JJ Baelde; Pancras Hogendoorn
Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts).
British journal of cancer 2001;84(4):535-8.
2001: A E Odink; Christi J van Asperen; J P Vandenbroucke; Anne-Marie Cleton-Jansen; Pancras Hogendoorn
An association between cartilaginous tumours and breast cancer in the national pathology registration in The Netherlands points towards a possible genetic trait.
The Journal of pathology 2001;193(2):190-2.
2000: Judith Bovee; L J C M van den Broek; Anne-Marie Cleton-Jansen; Pancras Hogendoorn
Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma.
Laboratory investigation; a journal of technical methods and pathology 2000;80(12):1925-34.
2000: Nathalie L G Sieben; Natalja T Ter Haar; Cees J Cornelisse; Gert Jan Fleuren; Anne-Marie Cleton-Jansen
PCR artifacts in LOH and MSI analysis of microdissected tumor cells.
Human pathology 2000;31(11):1414-9.
2000: Judith Bovee; M van Royen; A F Bardoel; Carla Rosenberg; Cees J Cornelisse; Anne-Marie Cleton-Jansen; Pancras Hogendoorn
Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma.
The American journal of pathology 2000;157(5):1587-95.
2000: Judith Bovee; J F Graadt van Roggen; Anne-Marie Cleton-Jansen; Antonie H M Taminiau; Henk-Jan van der Woude; Pancras Hogendoorn
Malignant progression in multiple enchondromatosis (Ollier's disease): an autopsy-based molecular genetic study.
Human pathology 2000;31(10):1299-303.
2000: BA Bonsing; Willem E Corver; Gert Jan Fleuren; Anne-Marie Cleton-Jansen; Peter Devilee; Cees J Cornelisse
Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases.
Genes, chromosomes & cancer 2000;28(2):173-83.
2000: M van der Looij; Anne-Marie Cleton-Jansen; Ronald van Eijk; Hans Morreau; Marcel van Vliet; Nel J Kuipers-Dijkshoorn; Edith Oláh; Cees J Cornelisse; Peter Devilee
A sporadic breast tumor with a somatically acquired complex genomic rearrangement in BRCA1.
Genes, chromosomes & cancer 2000;27(3):295-302.
1999: Judith Bovee; Anne-Marie Cleton-Jansen; Carla Rosenberg; Antonie H M Taminiau; Cees J Cornelisse; Pancras Hogendoorn
Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis.
The Journal of pathology 1999;189(4):454-62.
1999: CB Vos; Natalja T Ter Haar; Carla Rosenberg; Johannes L Peterse; Anne-Marie Cleton-Jansen; Cees J Cornelisse; Marc J van de Vijver
Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type.
British journal of cancer 1999;81(8):1410-8.
1999: Judith Bovee; Anne-Marie Cleton-Jansen; Nel J Kuipers-Dijkshoorn; L J C M van den Broek; Antonie H M Taminiau; Cees J Cornelisse; Pancras Hogendoorn
Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma.
Genes, chromosomes & cancer 1999;26(3):237-46.
1999: Maria Savino; Maria D'Apolito; Marta Centra; Hetty M van Beerendonk; Anne-Marie Cleton-Jansen; Scott A Whitmore; Joanna Crawford; David F Callen; Leopoldo Zelante; Anna Savoia
Characterization of copine VII, a new member of the copine family, and its exclusion as a candidate in sporadic breast cancers with loss of heterozygosity at 16q24.3.
Genomics 1999;61(2):219-26.
1999: Judith Bovee; Anne-Marie Cleton-Jansen; Wim Wuyts; G Caethoven; Antonie H M Taminiau; Egbert Bakker; W Van Hul; Cees J Cornelisse; Pancras Hogendoorn
EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas.
American journal of human genetics 1999;65(3):689-98.
1999: C Settasatian; Scott A Whitmore; Joanna Crawford; R L Bilton; Anne-Marie Cleton-Jansen; Grant R Sutherland; David F Callen
Genomic structure and expression analysis of the spastic paraplegia gene, SPG7.
Human genetics 1999;105(1-2):139-44.
1999: Anne-Marie Cleton-Jansen; Elna W Moerland; Jan C Pronk; Carola G M van Berkel; S Apostolou; Joanna Crawford; Anna Savoia; Arleen D Auerbach; Christopher G Mathew; David F Callen; Cees J Cornelisse
Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3.
British journal of cancer 1999;79(7-8):1049-52.
1999: Joanna Crawford; L Ianzano; Maria Savino; Scott A Whitmore; Anne-Marie Cleton-Jansen; C Settasatian; Maria D'Apolito; Ram Seshadri; Jan C Pronk; Arleen D Auerbach; Peter C Verlander; Christopher G Mathew; Alex J Tipping; Norman A Doggett; Leopoldo Zelante; David F Callen; Anna Savoia
The PISSLRE gene: structure, exon skipping, and exclusion as tumor suppressor in breast cancer.
Genomics 1999;56(1):90-7.
1998: Scott A Whitmore; C Settasatian; Joanna Crawford; Karen M Lower; B McCallum; Ram Seshadri; Cees J Cornelisse; Elna W Moerland; Anne-Marie Cleton-Jansen; Alex J Tipping; Christopher G Mathew; M Savnio; Anna Savoia; Peter C Verlander; Arleen D Auerbach; Carola G M van Berkel; Jan C Pronk; Norman A Doggett; David F Callen
Characterization and screening for mutations of the growth arrest-specific 11 (GAS11) and C16orf3 genes at 16q24.3 in breast cancer.
Genomics 1998;52(3):325-31.
1998: Scott A Whitmore; Joanna Crawford; S Apostolou; Helen Eyre; Elizabeth Baker; Karen M Lower; C Settasatian; S Goldup; Ram Seshadri; Robert Alan Gibson; Christopher G Mathew; Anne-Marie Cleton-Jansen; Anna Savoia; Jan C Pronk; Arleen D Auerbach; Norman A Doggett; Grant R Sutherland; David F Callen
Construction of a high-resolution physical and transcription map of chromosome 16q24.3: a region of frequent loss of heterozygosity in sporadic breast cancer.
Genomics 1998;50(1):1-8.
1997: Wiljo J F De Leeuw; G Berx; CB Vos; Johannes L Peterse; Marc J van de Vijver; Sergey V Litvinov; F Van Roy; Cees J Cornelisse; Anne-Marie Cleton-Jansen
Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
The Journal of pathology 1997;183(4):404-11.
1997: L Ianzano; Maria D'Apolito; Marta Centra; Maria Savino; Orna Levran; Arleen D Auerbach; Anne-Marie Cleton-Jansen; Norman A Doggett; Jan C Pronk; Alex J Tipping; Robert Alan Gibson; Christopher G Mathew; Scott A Whitmore; S Apostolou; David F Callen; Leopoldo Zelante; Anna Savoia
The genomic organization of the Fanconi anemia group A (FAA) gene.
Genomics 1997;41(3):309-14.
1997: Peter Devilee; J Hermans; Jorunn E Eyfjörd; A L Bøorresen; Rosette Lidereau; H Sobol; Ake Borg; Anne-Marie Cleton-Jansen; Edith Oláh; B B Cohen; Siegfried Scherneck; U Hamann; B Peterlin; MA Caligo; Y J Bignon; Christine Maugard
Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium.
Genes, chromosomes & cancer 1997;18(3):193-9.
1997: Elna W Moerland; Martijn H Breuning; Cees J Cornelisse; Anne-Marie Cleton-Jansen
Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes.
British journal of cancer 1997;76(12):1550-3.
1997: CB Vos; Anne-Marie Cleton-Jansen; G Berx; Wiljo J F De Leeuw; Natalja T Ter Haar; F van Roy; Cees J Cornelisse; Johannes L Peterse; Marc J van de Vijver
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
British journal of cancer 1997;76(9):1131-3.
1996: Geert Berx; Anne-Marie Cleton-Jansen; K Strumane; Wiljo J F De Leeuw; Friedel Nollet; Frans van Roy; Cees J Cornelisse
E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.
Oncogene 1996;13(9):1919-25.
1996: T Peelen; R S Cornelis; Marcel van Vliet; A Petrij-Bosch; Anne-Marie Cleton-Jansen; H Meijers-Heijboer; J G Klijn; H F A Vasen; Cees J Cornelisse; Peter Devilee
The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2.
European journal of human genetics : EJHG 1996;4(4):225-30.
1995: Geert Berx; Anne-Marie Cleton-Jansen; Friedel Nollet; Wiljo J F De Leeuw; Marc J van de Vijver; Cees J Cornelisse; Frans van Roy
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
The EMBO journal 1995;14(24):6107-15.
1995: Anne-Marie Cleton-Jansen; N Collins; S R Lakhani; J Weissenbach; Peter Devilee; Cees J Cornelisse; Michael R Stratton
Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
British journal of cancer 1995;72(5):1241-4.
1995: Anne-Marie Cleton-Jansen; H W Moerland; David F Callen; Norman A Doggett; Peter Devilee; Cees J Cornelisse
Mapping of the breast basic conserved gene (D16S444E) to human chromosome band 16q24.3.
Cytogenetics and cell genetics 1995;68(1-2):49-51.
1994: R S Cornelis; Marcel van Vliet; CB Vos; Anne-Marie Cleton-Jansen; Marc J van de Vijver; Johannes L Peterse; PM Khan; A L Børresen; Cees J Cornelisse; Peter Devilee
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cancer research 1994;54(15):4200-6.
1994: Richard Wooster; Anne-Marie Cleton-Jansen; N Collins; J Mangion; R S Cornelis; Colin S Cooper; Barry A Gusterson; Bruce A J Ponder; A von Deimling; O D Wiestler
Instability of short tandem repeats (microsatellites) in human cancers.
Nature genetics 1994;6(2):152-6.
1994: Anne-Marie Cleton-Jansen; Elna W Moerland; Nel J Kuipers-Dijkshoorn; David F Callen; G R Sutherland; B Hansen; Peter Devilee; Cees J Cornelisse
At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer.
Genes, chromosomes & cancer 1994;9(2):101-7.
1994: Anne-Marie Cleton-Jansen; H W Moerland; R H Vossen; David F Callen; Martijn H Breuning; Peter Devilee
Dinucleotide repeat polymorphism at D16S533.
Human molecular genetics 1994;3(1):216.
1993: BA Bonsing; Peter Devilee; Anne-Marie Cleton-Jansen; Nel J Kuipers-Dijkshoorn; Gert Jan Fleuren; Cees J Cornelisse
Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.
Cancer research 1993;53(16):3804-11.
1991: Anne-Marie Cleton-Jansen; S Dekker; P van de Putte; Nora Goosen
A single amino acid substitution changes the substrate specificity of quinoprotein glucose dehydrogenase in Gluconobacter oxydans.
Molecular & general genetics : MGG 1991;229(2):206-12.
1990: Anne-Marie Cleton-Jansen; Nora Goosen; O Fayet; P van de Putte
Cloning, mapping, and sequencing of the gene encoding Escherichia coli quinoprotein glucose dehydrogenase.
Journal of bacteriology 1990;172(11):6308-15.
1989: Anne-Marie Cleton-Jansen; Nora Goosen; K Vink; P van de Putte
Cloning, characterization and DNA sequencing of the gene encoding the Mr 50,000 quinoprotein glucose dehydrogenase from Acinetobacter calcoaceticus.
Molecular & general genetics : MGG 1989;217(2-3):430-6.
1989: Anne-Marie Cleton-Jansen; Nora Goosen; K Vink; P van de Putte
Cloning of the genes encoding the two different glucose dehydrogenases from Acinetobacter calcoaceticus.
Antonie van Leeuwenhoek 1989;56(1):73-9.
1988: Anne-Marie Cleton-Jansen; Nora Goosen; G Odle; P van de Putte
Nucleotide sequence of the gene coding for quinoprotein glucose dehydrogenase from Acinetobacter calcoaceticus.
Nucleic acids research 1988;16(13):6228.
1988: Anne-Marie Cleton-Jansen; Nora Goosen; T J Wenzel; P van de Putte
Cloning of the gene encoding quinoprotein glucose dehydrogenase from Acinetobacter calcoaceticus: evidence for the presence of a second enzyme.
Journal of bacteriology 1988;170(5):2121-5.